Living with a chronic condition often involves more than just managing physical symptoms; it creates a lasting impact on a person’s autonomy, mental health, and social life that current clinical standards often fail to capture.
A new report by the Plataforma de Organizaciones de Pacientes (POP) and consulting firm IQVIA, titled Vivir con una enfermedad crónica en el largo plazo: impacto en la calidad de vida de las personas, highlights the need for a more systematic integration of patient-reported experiences into healthcare, according to Somospacientes.
Researchers reviewed 762 scientific publications and ultimately selected 68 studies to analyze how Health-Related Quality of Life (HRQoL) evolves for chronic patients. This metric measures how patients perceive their own physical, emotional, and social well-being, including their ability to maintain personal relationships and perform daily tasks.
The report reveals that the health repercussions for this population are multidimensional and persistent. Physical limitations, pain, and fatigue are common, but the emotional and social impacts matter just as much.
In patients with chronic inflammatory diseases, the studies reviewed identified anxiety in up to 58% of individuals and depression in 40%, somospacientes.com reported. As diseases progress or treatment burdens increase, patients often report worsening quality of life, which can further exacerbate clinical outcomes.
For example, in heart failure cases, a decrease of ten points on a standard HRQoL scale was linked to a 12% increase in mortality risk and a 14% rise in hospitalizations.
The POP argues that these patient-reported outcomes (PROs) should carry the same weight as traditional clinical indicators. Currently, the assessment of these experiences relies on a variety of standardized tools known as PROMs.
| Tool Type | Percentage of Use |
|---|---|
| Generic quality of life questionnaires | 53% |
| Disease-specific questionnaires | 27% |
| Symptom or functionality instruments | 20% |
While this variety allows for specialized data collection, it also complicates comparisons across different pathologies. Furthermore, the report notes a significant imbalance in current research. Approximately 25% of the studies analyzed focus on oncology, while 19% address cardiovascular diseases. Rare, genetic, and mental health conditions remain significantly underrepresented in long-term longitudinal studies.
Research tracking patients for periods longer than a decade remains scarce, despite the fact that many individuals live with chronic conditions for the majority of their lives. The findings from this review were presented as a scientific poster at ISPOR Europe 2026.
To address these gaps, the POP has developed the CROBI scale, a tool designed to evaluate the biopsychosocial impact of chronic illness. The organization intends to move toward making such measurements a standard component of routine chronic care.